Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Providing Expert Treatment for all Urologic and Genitourinary Cancers
The doctors of the Stanford Urologic Cancer Program are dedicated to preserving quality of life and providing exceptional care through customized treatment plans for each patient. The program focuses on the investigation and management of cancers of the prostate, bladder, kidney, testis, and genitalia. Emphasis is placed on finding cancer treatments that take a multi-specialty approach to offer the greatest efficacy with the fewest complications.
Care and Treatment of Bladder, Kidney, Prostate, Urethra, and Testicular Cancers
Stanford Urologic and Genitourinary Cancers Expertise
Focused on cancers of the bladder, kidney, prostate, urethra and testes, the Stanford Urologic Cancer team offers superior diagnostic and screening capabilities, advanced radiation therapy procedures, and surgical expertise honed from years of experience. In addition to a multispecialty Tumor Board of urologic cancer experts that reviews complex cases and develops customized treatment plans, our program also addresses the psycho-social component of genitourinary/ urologic cancers. Lectures and monthly interactive support groups include doctors, patients, and families.
Improved tumor typing of urologic cancers that can enhance treatment recommendations
Novel stem cell research in bladder cancer
Improved visualization techniques for early detection and evaluation of response to therapeutics
Important discoveries in the hedgehog signaling pathway, which have led to new investigational treatments for prostate cancer
Minimally invasive and robotic surgery for prostate, bladder and kidney cancer
Neobladder reconstruction for patients requiring bladder removal for bladder cancer
Advanced imaging capabilities using new tracers for the detection of early and advanced cancer
Immunotherapies for castration-resistant prostate cancer and high dose interleukin-2 for advanced kidney cancer
Clinical trials with the latest investigational therapies and combination treatments
Cryoablation for kidney cancer
Partnering for Excellence
The Stanford Comprehensive Cancer Network is part of the Stanford Comprehensive Cancer Care Institute, an NCI-designated comprehensive cancer center.
Check out this infographic that explains what you should know about prostate cancer.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Maps, directions, parking, public transit options, and contact information
Other patient resources
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.